Emerging therapeutic targets for idiopathic pulmonary fibrosis: preclinical progress and therapeutic implications-Reference-Cited by-同舟云学术

Emerging therapeutic targets for idiopathic pulmonary fibrosis: preclinical progress and therapeutic implications

Published:2021-11-02 Issue:11 Volume:25 Page:939-948
ISSN:1472-8222
Container-title:Expert Opinion on Therapeutic Targets
language:en
Short-container-title:Expert Opinion on Therapeutic Targets

Author:

Yanagihara Toyoshi¹²^ORCID,Scallan Ciaran³^ORCID,Ask Kjetil³^ORCID,Kolb Martin R. J.³^ORCID

Affiliation:

1. Research Institute for Diseases of the Chest, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan

2. Department of Respiratory Medicine, Hamanomachi Hospital, Fukuoka, Japan

3. Firestone Institute for Respiratory Health, Research Institute at St Joseph’s Healthcare, Department of Medicine, McMaster University, Hamilton, ON, Canada

Publisher

Informa UK Limited

Subject

Clinical Biochemistry,Drug Discovery,Pharmacology,Molecular Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14728222.2021.2006186

Reference99 articles.

1. An Official ATS/ERS/JRS/ALAT Statement: Idiopathic Pulmonary Fibrosis: Evidence-based Guidelines for Diagnosis and Management

2. The increasing mortality of idiopathic pulmonary fibrosis: fact or fallacy?

3. Global incidence and mortality of idiopathic pulmonary fibrosis: a systematic review

4. Clinical Course and Prediction of Survival in Idiopathic Pulmonary Fibrosis

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unraveling the mechanism of ethyl acetate extract from Prismatomeris connata Y. Z. Ruan root in treating pulmonary fibrosis: insights from bioinformatics, network pharmacology, and experimental validation;Frontiers in Immunology;2024-01-08

2. Animal models of acute exacerbation of pulmonary fibrosis;Respiratory Research;2023-11-25

3. Application and Study of ROCK Inhibitors in Pulmonary Fibrosis: Recent Developments and Future Perspectives;Journal of Medicinal Chemistry;2023-03-20

4. Nintedanib in chILD: a small step, yes… but at least a step forward in a marathon!;European Respiratory Journal;2023-02

5. Diagnostic and prognostic value of secreted phosphoprotein 1 for idiopathic pulmonary fibrosis: a systematic review and meta-analysis;Biomarkers;2022-11-29